Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stable neurological function in subjects treated with 2'3'-dideoxyinosine

J J Sidtis1, U Dafni, P Slasor

  • 1Department of Neurology, University of Minnesota, Minneapolis, USA.

Journal of Neurovirology
|June 1, 1997
PubMed
Summary

Didanosine (DDI) therapy demonstrated stable neurologic performance in patients with advanced HIV infection over one year. DDI showed comparable efficacy to zidovudine (ZDV) in preventing AIDS Dementia Complex (ADC).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First results from the LUX dark matter experiment at the Sanford underground research facility.

Physical review letters·2014
Same author

The VANILLA sensor as a beam monitoring device for X-ray radiation therapy.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2013
Same author

Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.

Clinical and experimental immunology·2013
Same author

Long-term mortality following bloodstream infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Same author

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study.

Gynecologic oncology·2012
Same author

Metformin in obese children and adolescents: the MOCA trial.

The Journal of clinical endocrinology and metabolism·2012

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Background:

  • AIDS Dementia Complex (ADC) is a significant complication of HIV infection.
  • Zidovudine (ZDV) shows efficacy in alleviating and potentially preventing ADC.
  • Evaluating new antiretroviral therapies for neurologic side effects and ADC prevention relative to ZDV is crucial.

Purpose of the Study:

  • To assess the effects of 2'3'-dideoxyinosine (DDI, didanosine) on neuropsychological performance.
  • To compare DDI's efficacy in preventing ADC with that of ZDV.
  • To evaluate DDI's safety regarding neurologic side effects in advanced HIV-1 infection.

Main Methods:

  • Analysis of neuropsychological performance data from large clinical trials.
  • Quantitative testing over a 1-year period for subjects receiving DDI therapy.

Related Experiment Videos

  • Comparison of DDI-treated subjects with those receiving ZDV.

    • Main Results:

    • Neuropsychological performance remained stable in subjects treated with DDI over one year.
    • DDI treatment showed comparable results to ZDV treatment in quantitative neurologic tests.
    • No significant adverse neurologic effects were reported for DDI in this context.

    Conclusions:

    • Didanosine (DDI) is a viable antiretroviral therapy option for advanced HIV-1 infection.
    • DDI demonstrates comparable efficacy to ZDV in maintaining neurologic function and preventing ADC.
    • Further research into DDI's long-term neurologic effects and safety profile is warranted.